MARKET

RCM

RCM

R1 RCM
NASDAQ

Real-time Quotes | Nasdaq Last Sale

24.46
+0.37
+1.54%
After Hours: 24.46 0 0.00% 17:03 05/18 EDT
OPEN
24.10
PREV CLOSE
24.09
HIGH
24.90
LOW
23.79
VOLUME
805.87K
TURNOVER
--
52 WEEK HIGH
31.28
52 WEEK LOW
9.83
MARKET CAP
6.40B
P/E (TTM)
-11.4038
1D
5D
1M
3M
1Y
5Y
R1 RCM and Mednax announce agreement
R1 RCM ([[RCM]] -3.2%) and Mednax ([[MD]] -0.3%) have entered into an agreement that will make R1 the primary provider of enterprise revenue cycle management services for Mednax. The agreement is
Seekingalpha · 1d ago
R1 RCM and Mednax Announce Enterprise Revenue Cycle Management Agreement to Enhance Patient Experience and Drive Financial Performance
R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, and Mednax, Inc. (NYSE:MD), a national medical group specializing in prenatal, neonatal and...
GlobeNewswire · 1d ago
SQN Investors LP Buys HubSpot Inc, Bill.com Holdings Inc, Cloudflare Inc, Sells NICE, ...
GuruFocus News · 4d ago
Shareholders Will Likely Find R1 RCM Inc.'s (NASDAQ:RCM) CEO Compensation Acceptable
Shareholders may be wondering what CEO Joe Flanagan plans to do to improve the less than great performance at R1 RCM...
Simply Wall St. · 4d ago
Analysts’ Opinions Are Mixed on These Services Stocks: R1 RCM (RCM) and ViacomCBS (VIAC)
Analysts have been eager to weigh in on the Services sector with new ratings on R1 RCM (RCM) and ViacomCBS (VIAC). R1 RCM (RCM) RBC Capital analyst Sean
SmarterAnalyst · 05/07 01:45
Medical Billing Outsourcing Market Outlook Continues to Remain Positive by 2017 - 2027
May 06, 2021 (Heraldkeepers) -- Browse More Related Research Reports : https://www.marketresearchfuture.com/reports/mouth-ulcer-treatment-market-6421...
Heraldkeepers · 05/06 09:52
Revenue Cycle Management Market Size, Share, Emerging Trends, Demand, Revenue and Forecasts Research 2027
May 05, 2021 (The Expresswire) -- Revenue Cycle Management Market | 2021 Size, Growth, Share, Cap, Regional Analysis With Global Industry Forecast To 2027,...
The Express Wire · 05/05 05:13
R1 RCM Inc. (RCM) Reports Q1 Loss, Tops Revenue Estimates
R1 RCM Inc. (RCM) delivered earnings and revenue surprises of -2270.00% and 1.41%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 05/04 14:55
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of RCM. Analyze the recent business situations of R1 RCM through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average RCM stock price target is 35.00 with a high estimate of 37.00 and a low estimate of 33.00.
EPS
Institutional Holdings
Institutions: 290
Institutional Holdings: 107.33M
% Owned: 41.03%
Shares Outstanding: 261.59M
TypeInstitutionsShares
Increased
72
11.34M
New
25
1.69M
Decreased
81
8.54M
Sold Out
27
1.98M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
+1.08%
Healthcare Providers & Services
+0.55%
Key Executives
President/Chief Executive Officer/Director
Joseph Flanagan
Chief Financial Officer/Executive Vice President/Treasurer
Rachel Wilson
Chief Operating Officer/Executive Vice President
John Sparby
Executive Vice President
Vijay Kotte
Executive Vice President
Gary Long
Lead Director/Independent Director
Alex Mandl
Director
David Dill
Director
Anthony Speranzo
Director
Anthony Tersigni
Director
Albert Zimmerli
Independent Director
Michael Feiner
Independent Director
John Henneman
Independent Director
Neal Moszkowski
Independent Director
Ian Sacks
Independent Director
Jill Smith
No Data
About RCM
R1 RCM Inc. is a provider of revenue cycle management (RCM) and physician advisory services (PAS) to healthcare providers. The Company is engaged in providing management services of revenue cycle operations for the United States-based hospitals and other medical services providers. Its primary service offering consists of end-to-end RCM, which the Company deploys through a co-managed relationship or an operating partner relationship. The Company's PAS offering assists hospitals in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes. The Company also provides customers with retrospective appeal management service support for both governmental and commercial payers. Its physicians conduct detailed retrospective reviews of medical records to identify medical necessity for hospital services and the required documentation to support an appeal.

Webull offers kinds of R1 RCM Inc stock information, including NASDAQ:RCM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RCM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RCM stock methods without spending real money on the virtual paper trading platform.